Zymeworks ZYME
NASDAQ ZYME
$29.19 -0.71 (-2.37%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zymeworks (ZYME) Goodwill & Intangibles (2021 - 2026)

Zymeworks (ZYME) posted Goodwill & Intangibles of $13.2 million for Q1 2026, down 1.32% sequentially from $13.4 million in Q4 2025, and down 14.23% YoY from $15.4 million in Q1 2025.

Analysis

Zymeworks (ZYME) Goodwill & Intangibles (2021 - 2026) Analysis & Trends

Zymeworks has reported Goodwill & Intangibles for 6 years, with the latest figure at $13.2 million in Q1 2026.

  • Quarterly Goodwill & Intangibles fell 14.23% year-over-year to $13.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.2 million (down 14.23% YoY) and the FY2025 annual result came in at $13.4 million, down 19.44% from the prior year.
  • Goodwill & Intangibles eased to $13.2 million in Q1 2026 per ZYME's latest filing, from $13.4 million in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $29.6 million in Q4 2022 and troughed at $12.4 million in Q2 2024.
  • A 5-year average of $18.4 million and a median of $18.4 million in 2024 frame the typical range for Goodwill & Intangibles.
  • The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles sank 36.35% in 2024, then increased 13.79% in 2025.
  • Over 5 years, Goodwill & Intangibles stood at $29.6 million in 2022, then tumbled by 33.64% to $19.7 million in 2023, then declined by 15.66% to $16.6 million in 2024, then retreated by 19.44% to $13.4 million in 2025, then retreated by 1.32% to $13.2 million in 2026.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $13.2 million, $13.4 million, and $13.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Zymeworks 2.13 Bn 1.86 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.01 Mn
Mar 31, 2026 13.19 Mn
Dec 31, 2025 13.37 Mn
Sep 30, 2025 13.41 Mn
Jun 30, 2025 14.06 Mn
Mar 31, 2025 15.38 Mn
Dec 31, 2024 16.59 Mn
Sep 30, 2024 18.42 Mn
Jun 30, 2024 19.13 Mn
Mar 31, 2024 29.64 Mn
Dec 31, 2023 29.64 Mn
Sep 30, 2023 29.64 Mn
Jun 30, 2023 29.64 Mn
Mar 31, 2023 29.64 Mn
Dec 31, 2022 29.64 Mn
Sep 30, 2022 29.64 Mn
Dec 31, 2021 29.64 Mn